Relay Therapeutics: Breakthrough Designation Sets The Stage For A Key Zovegalisib Data Catalyst
Source: SeekingAlpha
2026-03-05 05:42:11 ET
Thesis
Read the full article on Seeking Alpha
For further details see:
Relay Therapeutics: Breakthrough Designation Sets The Stage For A Key Zovegalisib Data Catalyst
Relay Therapeutics Inc.
NASDAQ: RLAY
RLAY Trading
-2.13% G/L:
$9.425 Last:
508,709 Volume:
$9.31 Open:
RLAY Latest News
February 27, 2026 11:18:28 am
Relay Therapeutics Stock Up 235% This Past Year as One Fund Lifts Bet to $110 Million
February 26, 2026 04:05:00 pm
Relay Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Outlines Anticipated 2026 Milestones
February 23, 2026 04:05:00 pm
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March
RLAY Stock Data
$1,561,634,689
136,508,710
0.93%
61
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
